A glioblastoma neurosphere line with alternative lengthening of telomeres

Acta Neuropathologica

Volumn 126, Issue 4, 2013, Pages 607-608

  Heaphy, Christopher M ^a   Schreck, Karisa C ^a   Raabe, Eric ^a   Mao, Xing Gang ^a   An, Ping ^a   Chu, Qian ^a   Poh, Weijie ^a   Jiao, Yuchen ^a   Rodriguez, Fausto J ^a   Odia, Yazmin ^a   Meeker, Alan K ^a   Eberhart, Charles G ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAXX PROTEIN; ISOCITRATE DEHYDROGENASE 1; PROTEIN ATRX; PROTEIN P53; TELOMERASE; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ASTROCYTOMA; ATRX GENE; CANCER CELL CULTURE; CANCER GRADING; DAXX GENE; DNA METHYLATION; DNA SEQUENCE; ENZYME ACTIVITY; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENE LOCUS; GLIOBLASTOMA; GLIOMA CELL; HUMAN; IDH1 GENE; IMMUNOHISTOCHEMISTRY; LETTER; MUTATIONAL ANALYSIS; NONHUMAN; OSTEOARTHRITIS; PHENOTYPIC VARIATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; TELOMERE HOMEOSTASIS; TUMOR GENE; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; BRAIN NEOPLASMS; CELL LINE, TUMOR; DNA; DNA HELICASES; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; MALE; MUTATION; NUCLEAR PROTEINS; TELOMERASE; TELOMERE; TELOMERE SHORTENING;

EID: 84885484823     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-013-1174-x     Document Type: Letter

References (10)

1. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14:4240-4248
2. Nguyen DN, Heaphy CM, de Wilde RF, Orr BA, Odia Y, Eberhart CG et al (2012) Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol. doi: 10.1111/j.1750-3639.2012.00630.x
3. Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E et al (2011) Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 179:1608-1615
4. McDonald KL, McDonnell J, Muntoni A, Henson JD, Hegi ME, von Deimling A et al (2010) Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival. J Neuropathol Exp Neurol 69:729-736
5. Silvestre DC, Pineda JR, Hoffschir F, Studler JM, Mouthon MA, Pflumio F et al (2011) Alternative lengthening of telomeres in human glioma stem cells. Stem Cells 29:440-451
6. Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C et al (2011) Altered telomeres in tumors with ATRX and DAXX mutations. Science 333:425
7. Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N et al (2010) The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clin Cancer Res 16:6060-6070
8. Min JL, Meulenbelt I, Kloppenburg M, van Duijn CM, Slagboom PE (2007) Mutation analysis of candidate genes within the 2q33.3 linkage area for familial early-onset generalised osteoarthritis. Eur J Hum Genet 15:791-799
9. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773
10. Jiao Y, Killela PJ, Reitman ZJ, Rasheed AB, Heaphy CM, de Wilde RF et al (2012) Frequent ATRX, CIC, and FUBP1 mutations refine the classification of malignant gliomas. Oncotarget 3:709-722